IL6 and stroke disorder: Our data showed that RIPC reduced the levels of pro-inflammatory cytokines IL-1β, IL-6 and IFN-γ in the blood, and IL-1β and IFN-γ in the brain in aged rats 48 h post-stroke (Figure 3), while the changes that were neutralized by the HIF inhibitor (Figure 5).